Sriyankari Chitti was awarded a Barry M. Goldwater scholarship for her potential to contribute to the advancement of research in the natural sciences, mathematics or engineering.
- Researchers have developed the first computational model of a human cell and simulated its behavior for 15 minutes – the longest time achieved for a biological system of this complexity.
- Two Illinois Chemistry professors have received awards from The Protein Society for their individual researchProfessor Martin Gruebele and Research Professor Stephen G. Sligar are winners of the 2020 Protein Society Awards.
- Paul J. Hergenrother, the Kenneth L. Rinehart Endowed Chair in Natural Products Chemistry and Professor of Chemistry, has been appointed the deputy director of the Cancer Center at Illinois.
- Professor Jefferson Chan part of research identifying major landmarks of peripheral artery disease recoveryIllinois researchers used a suite of imaging methods to create the first holistic picture of peripheral artery disease recovery. Novel biomedical advances that show promise in the lab often fall short in clinical trials.
- As an undergraduate in chemistry at the University of Illinois, Dr. Jeanne Hankett (BS, ’10, chemistry) found her drive for analytical chemistry working in the lab of Professor Andy Gewirth, doing investigative work on oxygen reduction reaction electrocatalysis in relation to fuel cell development.
- The Department of Chemistry at the University of Illinois at Urbana-Champaign no longer requires Graduate Record Examination (GRE) scores for admission, a decision finalized in the summer of 2019. The current cycle of applicants is the first to have the option of foregoing GRE score submission.
- Atul K. Verma (PhD, ’96, Rauchfuss) was recognized at the Fall 2019 ACS National Meeting in San Diego with the ACS Heroes of Chemistry Award.
- The Chan group has recently developed a probe named CoxFluor, which is able to distinguish between Cyclooxygenase-2, an enzyme that plays a major role in driving the progression of cancer, and Cyclooxygenase-1, which is expressed in all cells.
- The Miniature Brain Machinery (MBM) program announces new trainees beginning in January 2020. Each new trainee represents an underrepresented demographic in our field.
- By folding snippets of DNA into the shape of a five-pointed star using structural DNA nanotechnology, researchers have created a trap that captures Dengue virus as it floats in the bloodstream. Once sprung, the trap – which is non-toxic and is naturally cleared from the body – lights up. It’s the most sensitive test for the mosquito-borne diseases yet devised.
- Professor Thomas Rauchfuss and collaborators are looking to biological processes to find an efficient source of hydrogen gas as an environmentally friendly fuelResearch from the University of Illinois and the University of California, Davis has chemists one step closer to recreating nature’s most efficient machinery for generating hydrogen gas. This new development may help clear the path for the hydrogen fuel industry to move into a larger role in the global push toward more environmentally friendly energy sources.
- The American Association for the Advancement of Science has announced Professor Paul Hergenrother as a 2019 FellowProfessor Paul J. Hergenrother, Kenneth L. Rinehart Jr. Endowed Chair in Natural Products Chemistry, is one of 443 newly elected Fellows into the American Association for the Advancement of Science (AAAS).
- Faculty members part of research looking into the link between migraines and the opioids used to treat themTo alleviate migraine pain, people are commonly treated with opioids. But, while opioid treatment can provide temporary pain relief for episodic migraines, prolonged use can increase the frequency and severity of painful migraines.
- A new web tool speeds the discovery of drugs to kill Gram-negative bacteria, which are responsible for the vast majority of antibiotic-resistant infections and deaths. The tool also offers insights into discrete chemical changes that can convert drugs that kill other bacteria into drugs to fight Gram-negative infections.